Patient-specific C. elegans model of Glycogen Storage Disease Type III shows significant glycogen accumulation. Through computational and drug screening approaches, CHK1 was identified as a potential modifier of disease-relevant phenotypes.
- Hiba Daghar
- Blake Pyman
- J. Alex Parker